GHRH analogue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-11-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | G-protein-coupled receptor on pituitary somatotrophs |
| Half-life, long-acting form | Several days | Extended by covalent albumin binding |
| Half-life, short form | About 30 minutes | Cleared rapidly by peptidases and kidneys |
| Route in studies | Subcutaneous injection | Used in the published human trials |
| Main measured effect | Rise in GH and IGF-1 | Surrogate markers rather than clinical endpoints |
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
In 1415, during the last phase of the Hundred Years' War, the Shroud was removed from the church of Lirey with the intention of depositing it temporarily at the castle of Montfort for safekeeping. Marguerite de Charny, the granddaughter of the knight who had endowed the church of Lirey, then took possession of the cloth and exhibited it at the church of Saint-Hippolyte, Doubs. Marguerite's refusal to return the Shroud to Lirey led to litigation. She carried the Shroud in traveling exhibitions, including to Chimay and Mons. In 1453 Marguerite deeded the Shroud to Louis, Duke of Savoy. For having sold the Shroud and disregarded the rights of the canons of Lirey, Marguerite was excommunicated by the curia of Besançon in 1457. The Shroud became the palladium of the House of Savoy, and by 1466 it had been deposited in the ducal chapel in Chambéry, the capital of the Savoyard state. In 1506 Pope Julius II authorized the veneration of the Shroud as a true relic of Jesus. In 1532 the Shroud was damaged by a fire in the chapel of Chambéry, when molten silver from the reliquary passed through the layers of folded cloth, leaving a symmetrical pattern of holes in the unfolded Shroud but without doing much damage to the image areas. The Poor Clare nuns in Chambéry later sewed patches over those holes. In 1578 Emmanuel Philibert, Duke of Savoy ordered the cloth to be brought to Turin, the new Savoyard capital, and it has remained in Turin ever since.
=== Branches === Ginkgo branches grow in length by growth of shoots with regularly spaced leaves, as seen on most trees. From the axils of these leaves, "spur shoots" (also known as short shoots) develop on second-year growth. Short shoots have short internodes (they may grow only one to two centimeters in several years) and their leaves are usually unlobed. They are short and knobby, and are arranged regularly on the branches except on first-year growth. Because of the short internodes, leaves appear to be clustered at the tips of short shoots, and reproductive structures are formed only on them (seeds and leaves are visible on short shoots). In ginkgos, as in other plants that possess them, short shoots allow the formation of new leaves in the older parts of the crown. After a number of years, a short shoot may change into a long (ordinary) shoot, or vice versa.
Quantitative structure–activity relationship (QSAR) models are regression or classification models used in the chemical and biological sciences and engineering. In QSAR regression models relate a set of "predictor" variables (X) to the potency of the response variable (Y), while classification QSAR models relate the predictor variables to a categorical value of the response variable. Nano-QSAR is the specialization of QSAR at the nanoscale. In QSAR modeling, the predictors consist of physico-chemical properties or theoretical molecular descriptors of chemicals; the QSAR response-variable could be a biological activity of the chemicals. QSAR models first summarize a supposed relationship between chemical structures and biological activity in a data-set of chemicals. Second, QSAR models predict the activities of new chemicals. Related terms include quantitative structure–property relationships (QSPR) when a chemical property is modeled as the response variable. "Different properties or behaviors of chemical molecules have been investigated in the field of QSPR. Some examples are quantitative structure–reactivity relationships (QSRRs), quantitative structure–chromatography relationships (QSCRs) and, quantitative structure–toxicity relationships (QSTRs), quantitative structure–electrochemistry relationships (QSERs), and quantitative structure–biodegradability relationships (QSBRs)." As an example, biological activity can be expressed quantitatively as the concentration of a substance required to give a certain biological response.
=== Ruminant metabolizable protein === The testing method for protein in beef cattle feed has grown into a science over the post-war years. The standard text in the United States, Nutrient Requirements of Beef Cattle, has been through eight editions over at least seventy years. The 1996 sixth edition substituted for the fifth edition's crude protein the concept of "metabolizeable protein", which was defined around the year 2000 as "the true protein absorbed by the intestine, supplied by microbial protein and undegraded intake protein". (This refers specifically to ruminant nutrition, where microbes living in the rumen can convert NPNs to proteins. Such conversion does not happen in non-ruminants such as humans.)
Robert Heller was brought in as the first editor of what became Management Today – Heseltine initially irritated him by taking him to lunch at the Carlton Club and talking of his political aspirations, but Heller soon recognised that Labovitch was the front man whose job was to impress those who needed to be impressed, and Heseltine was "the dynamic and real entrepreneurial brain". The first edition came out in April 1966, just after Heseltine's election to Parliament. Haymarket went on to publish similar magazines for Marketing, Personnel Management and Computing Institutes. Labovitch left Haymarket at the end of 1965. Heseltine stated he spent three days trying to persuade him to stay. Labovitch wanted to establish himself as a successful educational and careers publisher, and may well have been pushed by his then wife, the socialist journalist Penny Perrick, who disliked Heseltine both personally (as best man at their wedding he had, she said, welcomed various business figures in his speech as if he were at a board meeting) and politically and whom he had refused to include on the Haymarket board. Labovitch was a generator of ideas but he lacked Heseltine's business skills. Although he took his profitable Directories with him, he had to sell them back to Haymarket when his business failed in 1973, causing him to attempt suicide. Heseltine offered him a position as consultant to Haymarket. The two former partners remained on friendly terms until Labovitch's death in 1994. Very few staff left with Labovitch.
Sources: en.wikipedia.org
== Gene == In humans, the MAPT gene for encoding tau protein is located on chromosome 17q21, containing 16 exons. The major tau protein in the human brain is encoded by 11 exons. Exons 2, 3 and 10 are alternatively spliced, which leads to the formation of six tau isoforms. In the human brain, tau proteins constitute a family of six isoforms with a range of 352–441 amino acids. Tau isoforms are different in having either zero, one, or two inserts of 29 amino acids at the N-terminal part (exons 2 and 3) and three or four repeat-regions at the C-terminal part (exon 10). Thus, the longest isoform in the CNS has four repeats (R1, R2, R3 and R4) and two inserts (441 amino acids total), while the shortest isoform has three repeats (R1, R3 and R4) and no insert (352 amino acids total). The MAPT gene has two haplogroups, H1 and H2, in which the gene appears in inverted orientations. Haplogroup H2 is common only in Europe and in people with European ancestry. Haplogroup H1 appears to be associated with increased probability of certain dementias, such as Alzheimer's disease. The presence of both haplogroups in Europe means that recombination between inverted haplotypes can result in the lack of one of the functioning copies of the gene, resulting in congenital defects. The risk haplotype H1H1 in iPSC-derived cortical neurons revealed a higher expression of alpha-synuclein compared to H2H2, which may explain the association of haplotype with synucleinopathies such as Parkinson's disease.
== Related compounds == The naphthoquinones lawsone methyl ether and methylene-3,3'-bilawsone are some of the active compounds in Impatiens balsamina leaves. Juglone is a structural isomer used as a brown dye. Atovaquone is a synthetic antimicrobial agent that can be manufactured from lawsone.
Narrated by Miriam Margolyes, directed by Karl Sabbagh, made by Skyscraper Productions with KCTS 5 October The Mystery of Anastasia, an Equinox Special, about Anna Anderson; the Romanovs were murdered in Siberia on 17 July 1918; the Forensic Science Service at Aldermaston; forensic scientist William R. Maples; Peter Kurth; David Ellen, of Scotland Yard; Gleb Botkin; Peter Vanezis, Regius Professor of Forensic Medicine (Glasgow) and ears; former Danish ambassador to Germany Herluf Zahle; Ernest Louis, Grand Duke of Hesse hired detective Martin Knopf, who found Anna Anderson's possible name; Geoff Oxley, and facial recognition computing looking at Frances; Patrick Lincoln of London Hospital Medical College, and heredity of blood groups, and the A2 blood group; Peter French, who researched pronunciation; pathologist Hunt MacMillan III and Peter Gill of the Forensic Science Service (Birmingham); in Charlottesville in June 1994; David Enoch (psychiatrist) of the Royal Liverpool University Hospital; the Duke of Edinburgh provided a blood sample to prove mitochondrial DNA, as he was related to Anastasia; Prince Rostislav Rostislavovich Romanov (1938-1999), father of Prince Rostislav Romanov (born 1985); Kevin Sullivan of the Forensic Service; Anna Anderson was not Anastasia, according to mitochondrial DNA of the Duke of Edinburgh.
Skyline is an open source software for targeted proteomics and metabolomics data analysis. It runs on Microsoft Windows and supports the raw data formats from multiple mass spectrometric vendors. It contains a graphical user interface to display chromatographic data for individual peptide or small molecule analytes. Skyline supports multiple workflows including selected reaction monitoring (SRM) / multiple reaction monitoring (MRM), parallel reaction monitoring (PRM), data-independent acquisition (DIA/SWATH) and targeted data-dependent acquisition.
Sources: en.wikipedia.org
== Chimerism and intersex == The concept of a "human hermaphrodite" resulting from chimerism is largely a misconception. Most intersex individuals are not chimeras, and most human chimeras are not observed to have intersex traits. Theoretically, if a gynandromorphic human chimera were to have fully functioning male and female gonad tissue, such an individual could self-fertilize; this hypothesis is backed by the fact that hermaphroditic animal species commonly reproduce in this way, and it has been observed in a rabbit. However, no such case of functional self-fertilization has ever been documented in humans; and it is non-existent or extremely rare in mammals, especially in humans. While humans are known to have sex characteristics that diverge from typical males or typical females, these individuals fall under the social umbrella of intersex conditions and traits, and some consider the term "hermaphrodite" to be a slur when applied to them.
220 (5): 496.e1–496.e8. doi:10.1016/j.ajog.2019.01.218. PMID 30690015. S2CID 59342701. Sheng, C.; Jungverdorben, J.; Wiethoff, H.; Lin, Q.; Flitsch, L. J.; Eckert, D.; Hebisch, M.; Fischer, J.; Kesavan, J.; Weykopf, B.; Schneider, L.; Holtkamp, D.; Beck, H.; Till, A.; Wüllner, U.; Ziller, M. J.; Wagner, W.; Peitz, M.; Brüstle, O. (2018). "A Stably Self-Renewing Adult Blood-derived Induced Neural Stem Cell Exhibiting Pattern Ability and Epigenetic Rejuvenation". Nature Communications. 9 (1): 4047. Bibcode:2018NatCo...9.4047S. doi:10.1038/s41467-018-06398-5. PMC 6168501. PMID 30279449. López-Alcorocho, J. M.; Guillén-Vicente, I.; Rodríguez-Iñigo, E.; Guillén-Vicente, M.; Fernández-Jaén, T. F.; Caballero, R.; Casqueiro, M.; Najarro, P.; Abelow, S.; Guillén-García, P. (2019). "Study of Telomere Length in Preimplanted Cultured Chondrocytes". Cartilage. 10 (1): 36–42. doi:10.1177/1947603517749918. PMC 6376562. PMID 29322876. Salvador, L.; Singaravelu, G.; Harley, C. B.; Flom, P.; Suram, A.; Raffaele, J. M. (2016). "A Natural Product Telomerase Activator Lengthens Telomeres in Humans". Rejuvenation Research. 19 (6): 478–484. doi:10.1089/rej.2015.1793. PMC 5178008. PMID 26950204. Alda, M.; Puebla-Guedea, M.; Rodero, B.; Demarzo, M.; Montero-Marin, J.; Roca, M.; Garcia-Campayo, J. (2016). "Zen meditation, Length of Telomeres, and the Role of Experiential Avoidance and Compassion". Mindfulness. 7 (3): 651–659. doi:10.1007/s12671-016-0500-5. PMC 4859856. PMID 27217844. De Rooij, S. R.; Van Pelt, A. M.; Ozanne, S. E.; Korver, C. M.; Van Daalen, S. K.; Painter, R.
=== Chemiluminescence === This technology is based on the luminescence of specific compounds when they bind to explosive particles. Its sensitivity can reach the nanogram (ppb) level. It can be applied in non-electronic formats, such as sprays and test papers, as well as in electronic devices.
==== Section C: Biology and Food Technology ==== The activities of Section C deal with the application of refrigeration technologies to life sciences and food sciences. Commission C1 Cryobiology, cryomedicine and health products is particularly focused on the application of refrigeration technologies on various branches of medicine: cryosurgery and oncology, cryotherapy, blood, organs and tissue preservation, health products (especially vaccines and thermosensitive preparations). On the one hand, the work focuses on the biological and biochemical aspects of the effects of refrigeration on organs, tissues and treated products, and on the other hand, on the applied refrigeration techniques and technologies. Commission C2 food science and engineering is focused more particularly on the application of refrigeration technologies in the area of food sciences: preservation (refrigeration, freezing); hygiene and safety in its microbiological aspect; process (lyophilisation, cryoconcentration, cryoprecipitation, partial or total crystallisation). The work focuses on establishing a model for the transfer of heat and matter during refrigeration treatments, on the effects of refrigeration on food products, and on the evolution kinetics of products kept in cold storage. The work deals with the impact of the integrity of the cold chain on the quality of food, including in warm climate countries.
After hearing arguments for and against Luke, Viserys decides to reaffirm Luke's status as heir to Driftmark, which enrages Vaemond. Vaemond calls Rhaenyra a "whore" and her children "bastards", which angers Viserys into declaring that he will have Vaemond's tongue for such speech, though Daemon decapitates Vaemond before he can do so. Viserys hosts a feast among the two sides of his family, where he implores them to make amends for their past conflicts. Rhaenyra and Alicent compliment each other, and the family eats and laughs in harmony for the first time in years. Viserys is glad to see his family united, and departs for bed before Alicent and Rhaenyra's families become tense once again. As he lays in bed, Viserys mistakes Alicent for Rhaenyra and vocalizes Aegon the Conqueror's Song of Ice and Fire to her, with Alicent interpreting his words to mean that he wants her son Aegon to succeed him as king. He calls out to his "love" Aemma in his last words, and passes away shortly after on his bed.
Sources: en.wikipedia.org
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.
The drug affinity complex links the peptide to serum albumin through a covalent bond. The conjugate is too large to be filtered quickly by the kidneys and is shielded from enzymatic breakdown. This extends the apparent half-life from roughly minutes to several days.
Long-term safety and any clinical benefit are unestablished. Published human data cover small groups over limited periods and focus on hormone levels rather than health outcomes. Whether prolonged elevation of growth hormone and insulin-like growth factor 1 is beneficial or harmful is an open question.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.